Chantale Julien has re-joined Novo Nordisk Pharmatech
We are pleased to announce that Chantale Julien has re-joined Novo Nordisk Pharmatech on January 1st, 2020. Chantale will be acting as Global Product Manager for the FeF Quats and Insulin Human AF products.
Chantale has previously worked for Novo Nordisk Pharmatech for a period stretching over almost 13 years, where she has been acting as Product Manager, Regulatory Affairs Manager and Project Manager. She has been involved in establishing the Insulin Human AF distribution from Novo Nordisk Pharmatech and brings back a wide experience in the API and excipient sectors for our antimicrobial quaternary ammonium compounds.
We are happy to have an experienced employee back on the team. You are welcome to contact Chantale if you need technical advice, for new product-related projects, and general product information. You can find here contact information here.